"One of my greatest priorities is to reduce the price of prescription drugs." - President Donald J. Trump
A BURDEN ON THE AMERICAN PEOPLE: Drug prices are being driven up unfairly, taking a toll on the American people.
One of the more frustrating restrictions on the pharmacist-consumer relationship has long been the pharmacist’s inability to tell a customer about lower-cost drug purchasing options. Which is why pharmacists largely cheered when the Trump Administration announced in mid-May that it was eliminating the aptly named “gag rule” for Medicare Part D patients.
Contracts negotiated between pharmacies and pharmaceutical benefit managers (PBMs) often include a clause preventing pharmacists from alerting consumers if out-of-pocket costs for a drug would be cheaper if the consumer paid cash for the drug, rather than running the prescription through the consumer’s insurance company. In many instances, due to negotiated reimbursement rates, the insurance company-mandated co-pay is actually higher. But, due to the presence of the “gag rule,” pharmacists have been prohibited from sharing that information with their customers.
You can read the White House's briefing statement HERE